Delivery Order SPE2DB22D1200-SPE2DB24FN3EU
Award Date
6/20/24
Potential Completion Date
6/21/24
Potential Value
$2.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division is for the provision of Trumenba 120 mcg/0.5 ml vaccine in 0.5 ml doses. The firm-fixed-price delivery order has a ceiling value of $2,887.80 and an ultimate completion date of June 14, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a single-award Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999.00...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of TRUMENBA 120 MCG/0.5 ML VACCIN 0.5ML. The firm-fixed-price contract, valued at $4,950.60, has a performance period through May 9, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 held by Amerisourcebergen with the DLA Troop Support Medical, which serves as the...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of TRUMENBA 120 MCG/0.5 ML VACCIN 0.5ML, a vaccine product. The contract has a ceiling value of $1,222.33 and runs through March 5, 2025. It is a firm fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant...
This federal contract award from the Defense Logistics Agency (DLA) was issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,554.30 firm fixed-price delivery order is for the BOOSTRIX TDAP vaccine syringe 0.5mL, with a period of performance through November 4, 2024. No set-aside designation was used for this award. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The $35,965.16 firm-fixed-price delivery order is for the supply of 4,566,106,682 units of the BOOSTRIX TDAP vaccine syringe (0.5 ml). The award is not associated with a set-aside program. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,532.58 firm fixed-price delivery order is for the BOOSTRIX TDAP VACCINE SYRINGE 0.5ML product, with a completion date of November 5, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This federal contract award is for the delivery of BOOSTRIX TDAP VACCINE SYRINGE 0.5ML to the Defense Logistics Agency (DLA), a defense agency. The $7,319.00 firm-fixed-price contract was awarded to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, on July 8, 2024 with a completion date of July 9, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,848.26 firm fixed-price delivery order is for the BOOSTRIX TDAP vaccine syringe, 0.5 mL. The contract has a completion date of May 5, 2023 and was awarded on May 4, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of BOOSTRIX TDAP VACCINE SYRINGE 0.5ML. The $2,612.30 fixed-price delivery order contract has an ultimate completion date of March 5, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,850.00 firm fixed-price delivery order is for the supply of BOOSTRIX TDAP vaccine syringes (0.5 mL). The contract has an ultimate completion date of December 8, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026,...